Company: XERI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001477932-25-003761
Chunk: 41

Company: XERIANT, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 41
---
 Lease liability, current  4,174   36,197 Total current liabilities  8,660,102   9,325,459          Lease liability, long-term  4,215   - Total liabilities  8,664,317   9,325,459          Commitments and contingencies (Note 9)                 Stockholders’ deficit        Series A Preferred stock, $0.00001 par value; 100,000,000 authorized; 3,500,000 designated; 672,116 and 757,395 shares issued and outstanding at March 31, 2025 and June 30, 2024, respectively  7   7 Series B Preferred stock, $0.00001 par value; 100,000,000 authorized; 1,000,000 designated; 1,000,000 issued and outstanding  10   10 Common stock, $0.00001 par value; 5,000,000,000 shares authorized; 681,131,059 and 524,853,304 shares issued and outstanding at March 31, 2025 and June 30, 2024, respectively  6,811   5,248 Common stock to be issued  97,900   51,950 Additional paid in capital  22,192,742   20,899,187 Accumulated deficit  (28,011,467)  (26,708,915)Total stockholders’ deficit  (5,713,997)  (5,752,513)Non-controlling interest  (2,877,148)  (2,859,941)Total stockholders’ deficit  (8,591,145)  (8,612,454)Total liabilities and stockholders’ deficit $73,172  $713,005 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 F-2Table of Contents

XERIANT, INC.  

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 

UNAUDITED 

  For the three months ended  For the nine months ended   March 31,  March 31,   2025  2024  2025  2024 Operating expenses: